Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Adenosine receptor A2a | ||
Ligand | BDBM561428 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Adenosine A2A Receptor Cyclic AMP GS Assay | ||
Ki | <10±n/a nM | ||
Citation | Huang, T; Wang, X Pyrazolopyridines and triazolopyridines as A2A / A2B inhibitors US Patent US11390624 Publication Date 7/19/2022 | ||
More Info.: | Get all data from this article, Assay Method | ||
Adenosine receptor A2a | |||
Name: | Adenosine receptor A2a | ||
Synonyms: | A2A adenosine receptor (hA2A) | AA2AR_HUMAN | ADENOSINE A2 | ADENOSINE A2a | ADORA2 | ADORA2A | Adenosine A2A receptor (A2AAR) | ||
Type: | G Protein-Coupled Receptor (GPCR) | ||
Mol. Mass.: | 44716.46 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P29274 | ||
Residue: | 412 | ||
Sequence: |
| ||
BDBM561428 | |||
n/a | |||
Name | BDBM561428 | ||
Synonyms: | 3-(4-amino-7-(4-(hydroxymethyl)-2-methyloxazol-5-yl)-2-(pyridin-2-ylmethyl)-2H-[1,2,3]triazolo[4,5-c]pyridin-6-yl)-2-fluorobenzonitrile | US11390624, Example 42 | ||
Type | Small organic molecule | ||
Emp. Form. | C23H17FN8O2 | ||
Mol. Mass. | 456.4319 | ||
SMILES | Cc1nc(CO)c(o1)-c1c(nc(N)c2nn(Cc3ccccn3)nc12)-c1cccc(C#N)c1F |(-1.84,4.89,;-.93,3.64,;.61,3.64,;1.09,2.18,;2.55,1.7,;3.69,2.73,;-.16,1.27,;-1.41,2.18,;-.16,-.27,;-1.49,-1.04,;-1.49,-2.58,;-.16,-3.35,;-.16,-4.89,;1.17,-2.58,;2.64,-3.05,;3.54,-1.81,;5.08,-1.81,;5.85,-.47,;5.08,.86,;5.85,2.19,;7.39,2.19,;8.16,.86,;7.39,-.47,;2.64,-.56,;1.17,-1.04,;-2.83,-.27,;-2.83,1.27,;-4.16,2.04,;-5.5,1.27,;-5.5,-.27,;-6.83,-1.04,;-8.16,-1.81,;-4.16,-1.04,;-4.16,-2.58,)| | ||
Structure |